🇺🇸 FDA
Patent

US 8828380

Method for the treatment of pulmonary disease and method of producing proteins of use therein

granted A61KA61K31/7084A61K38/16

Quick answer

US patent 8828380 (Method for the treatment of pulmonary disease and method of producing proteins of use therein) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/7084, A61K38/16, A61K38/17, A61K38/1729